Below you will find a list of the trials and studies being run by members of the Cambridge Pancreatic Cancer Centre. To learn more about pancreatic cancer clinical trials running across the UK, you can check out the Cancer Research UK trial finder page or the Pancreatic Cancer UK trial finder page. You might be interested in our previous clinical trials and research studies.
Tissue/blood collection
MIPPaC: Understanding the mechanisms underlying weight loss in people with cancer by investigating changes to metabolism and the immune system
Learn MorePrecision-Panc: Advancing personalised medicine treatment strategies for pancreatic cancer
Learn MorePancrea_tive: Investigating tumour-stroma heterogeneity in human pancreatic cancer and pancreatic diseases
Learn MoreLocally advanced
STARPAC2 (Primus-05): Phase IIb randomised clinical trial repurposing ATRA as a stromal targeting agent in a novel drug combination for pancreatic cancer
Learn MoreMetastatic - 1st or 2nd line
PRIMUS-001: An adaptive phase II study of FOLFOX-A (FOLFOX and nab-paclitaxel) versus AG (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation
Learn MorePemOla: A phase II study combining pembrolizumab (anti-PD-1R Ab) with olaparib (PARP inhibitor) in metastatic PDAC patients with mismatch repair deficiency or tumour mutation burden > 4 mutations/Mb
Learn MoreMetastatic - 2nd line and beyond
ATRiUM: A Phase I clinical trial looking at AZD6738 (ATR inhibitor) in combination with Gemcitabine
Learn More